BioMarin Pharmaceutical Inc. (BMRN) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
5/20/2013 9:38:37 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
SAN RAFAEL, Calif., May 20, 2013 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that on May 15, 2013, the compensation committee of BioMarin's board of directors approved the grant to 32 employees of stock options to purchase 33,900 shares of common stock in the aggregate and the grant to 29 of the 32 employees of 7,710 restricted stock units in the aggregate. The stock options were granted pursuant to the BioMarin Pharmaceutical Inc. 2012 Inducement Plan, approved by the compensation committee of BioMarin's board of directors on May 8, 2012, and as inducements material to the new employees entering into employment with BioMarin in accordance with NASDAQ Listing Rule 5635(c)(4).
Help employers find you! Check out all the jobs and post your resume.
comments powered by